Literature DB >> 25168568

The influence of urinary pH on antibiotic efficacy against bacterial uropathogens.

Luo Yang1, Kunjie Wang2, Hong Li2, John D Denstedt3, Peter A Cadieux4.   

Abstract

OBJECTIVE: To determine the effects of pH on the activity of clinically relevant antibiotics against bacterial uropathogens. Numerous factors affect antibiotic efficacy within the urinary tract including pH. Because human urine can substantially vary from acidic (pH 4.5) to alkaline (pH 8) conditions and can be easily clinically manipulated, it would be a great advantage to better understand the role of pH in antibiotic treatment of urinary tract infection.
MATERIALS AND METHODS: This in vitro study investigated the activity of 24 widely used antimicrobial agents against bacterial strains comprising 6 major uropathogenic species (Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis, Staphylococcus saprophyticus, and Staphylococcus epidermidis) over the range of pH 5-8. Standard disk-diffusion and broth-microdilution assays were used. One-way analysis of variance was applied to determine significance (P <.05).
RESULTS: For 18 of the 24 agents, pH was shown to play a significant role in overall inhibitory activity. Although most agents behaved similarly across most or all of the uropathogens tested, several only showed pH-dependent effects against certain organisms. The fluoroquinolones, co-trimoxazole, aminoglycosides, and macrolides all functioned optimally at alkaline pH, whereas the tetracyclines, nitrofurantoin, and many of the β-lactams tested exhibited their highest activity under more acidic conditions. Sulfamethoxazole, oxacillin, amoxicillin and clavulanic acid, vancomycin, imipenem, and clindamycin were largely unaffected by pH.
CONCLUSION: Clinicians should consider the urinary pH of their patients when treating urinary tract infection, especially in complicated scenarios. Future clinical investigations examining urinary pH and antibiotic efficacy may result in the application of decreased antibiotic dosages and regimen durations, potentially reducing antibiotic resistance development.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25168568     DOI: 10.1016/j.urology.2014.04.048

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  25 in total

1.  An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant Gram-negative uropathogens: the importance of urinary antibiotic concentrations and urinary pH.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-09       Impact factor: 3.267

2.  Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

Authors:  B A Cunha; C B Cunha; B Lam; J Giuga; J Chin; V F Zafonte; S Gerson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-02       Impact factor: 3.267

3.  Predictors of ertapenem therapeutic efficacy in the treatment of urinary tract infections (UTIs) in hospitalized adults: the importance of renal insufficiency and urinary pH.

Authors:  B A Cunha; J Giuga; S Gerson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

4.  Antibiotic-induced DNA damage results in a controlled loss of pH homeostasis and genome instability.

Authors:  James Alexander Booth; Mário Špírek; Tekle Airgecho Lobie; Kirsten Skarstad; Lumir Krejci; Magnar Bjørås
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

5.  Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.

Authors:  Nayara Helisandra Fedrigo; Josmar Mazucheli; James Albiero; Danielle Rosani Shinohara; Fernanda Gomes Lodi; Ana Cristina Dos Santos Machado; Sherwin K B Sy; Maria Cristina Bronharo Tognim
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

6.  Clinical and Laboratory Profile of Urinary Tract Infections in Type 2 Diabetics Aged over 60 Years.

Authors:  Sadhna Sharma; Biju Govind; Sujeet Kumar Naidu; Srinivas Kinjarapu; Mohammed Rasool
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 7.  Potential new fluoroquinolone treatments for suspected bacterial keratitis.

Authors:  Rose Herbert; Mary Caddick; Tobi Somerville; Keri McLean; Shakeel Herwitker; Timothy Neal; Gabriela Czanner; Stephen Tuft; Stephen B Kaye
Journal:  BMJ Open Ophthalmol       Date:  2022-07

8.  Efficacy of oral moxifloxacin for aerobic vaginitis.

Authors:  C Wang; C Han; N Geng; A Fan; Y Wang; Y Yue; H Zhang; F Xue
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-02       Impact factor: 3.267

9.  In vitro antibacterial activity of ceftazidime, unlike ciprofloxacin, improves in the presence of ZnO nanofluids under acidic conditions.

Authors:  Jalil Javedani Bafekr; Razieh Jalal
Journal:  IET Nanobiotechnol       Date:  2018-08       Impact factor: 1.847

10.  Direct microfluidic antibiotic resistance testing in urine with smartphone capture: significant variation in sample matrix interference between individual human urine samples.

Authors:  Sarah Helen Needs; Sultan İlayda Dönmez; Alexander Daniel Edwards
Journal:  RSC Adv       Date:  2021-11-29       Impact factor: 3.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.